関連する実験動画
Updated: Jul 20, 2026
17:42
A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
Published on: April 13, 2011
まとめ
グルココルチコイド誘発型糖尿病は,腎臓移植患者の5.5%で発生しました. ステロイド型糖尿病患者の大半は機能する腎臓で生存し,長期にわたるインスリン療法が必要な患者はほとんどいなかった.
科学分野:
- ネフロロジーは腎臓科
- エンドクリノロジー エンドクリノロジー
- 移植手術 移植手術について
背景:
- 腎臓アロ移植を受けた患者は,しばしばグルココルチコイドを投与されます.
- グルココルチコイドは,高血糖症を引き起こすことが知られている.
- 手術後のストレスや特定の薬剤は,高血糖症を悪化させる可能性があります.
研究 の 目的:
- ステロイド (グルココルチコイド) 糖尿病の発生率を腎臓アロインプラント受容者において決定する.
- 移植後の高血糖症を発症する患者のアウトカムを評価する.
主な方法:
- 202人の腎臓アロインプラント受験者の遡及的分析.
- ハイパーグリセミアとステロイド糖尿病の発症をモニタリングする.
- 患者の生存率とアロインプラントの機能を追跡する.
主要な成果:
- 11人の患者 (5.5%) がステロイド糖尿病を発症した.
- 3人の患者は,ハイパロスモラー非ケト症候群を示し,全員が回復しました.
- 11人の患者のうち8人が機能するアロ移植で生存し,1人だけがインスリンを必要とした.
結論:
- ステロイド型糖尿病は,腎臓移植を受けた患者の重要な合併症です.
- ハイパーグリセミアは,手術直後の期間に一般的です.
- このコホートにおけるステロイド糖尿病のアウトカムは一般的に好意的であり,ほとんどの患者は移植機能と最小限のインスリン依存性を維持しました.
関連する概念動画
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...